USFDA finds probable human carcinogen in Zantac | Lifestyle News, The Indian Express

USFDA finds probable human carcinogen in Zantac | Lifestyle News, The Indian Express

By Lifestyle Desk |New Delhi |Published: September 14, 2019 1:59:00 pm

USFDA finds probable human carcinogen in Zantac

The USFDA has not yet called for Sanofi, the company that manufactures Zantac, to recall it from the market, but has urged people to exercise caution and consult a doctor or a pharmacist before taking a decision.

Strictly speaking, it is the ranitidine medication — sold under the trade name Zantac — that reduces stomach acid production. (Source: Getty/Thinkstock)

Does Zantac cause cancer? The United States Food and Drug Administration (USFDA) has found low-level human carcinogen in some versions of the popular over-the-counter heartburn drug.